Ayurvedic treatment of katigrah(Lumbar Spondylosis).

Phase 2

• Conditions: Health Condition 1: M45-M49- Spondylopathies

• Registration Number: CTRI/2019/06/019952
• Lead Sponsor: Self Swapnalee Shanklar More PG Kayachikitsa

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 24 November 2021

Recruitment & Eligibility

• Status: ot Yet Recruiting
• Sex: Not specified
• Target Recruitment: 0

Inclusion Criteria

1. The Roland and Morris low back pain and disability questionnaire; if RDQ score > 5

2. Radiological degenerative changes in Lumbar spine.

3. Patients having sign and symptoms of Katigrah according to classics.

4. Patient willing and able to participate in the study.

5. Chronic low back pain more than three months.

6. Patients of either sex aged between 18- 70 years irrespective of caste, religion, socio economic & educational status.

Exclusion Criteria

1. History of any fracture of vertebral joint/ surgical/ diagnostic intervention with reference to affected joints will be excluded.

2. Gross disability in performing daily normal routine i.e. bedridden patient or confined to a wheelchair will be excluded.

3. Patient with co-morbidities such as gouty arthritis, rheumatoid arthritis or psoriatic arthritis and tubercular arthritis.

4. Patient with any deformity of hip or back altering the gait and posture of the patient, ankylosing spondylitis, pelvic inflammatory disorders.

5. Patient with uncontrolled hypertension (>=160/100mm of Hg) and uncontrolled diabetes (Blood sugar level fasting >125mg/dl and post lunch >200mg/dl) will be ruled out.

6. Patient with evidence of malignancy.

7. Patient on prolonged (>=6weeks) medication with corticosteroids, non-steroidal antiinflammatory drug, antidepressants, anti-cholinergic etc. or any drugs that may influence on the outcome of the study.

8. Patient who have a past history of any other systemic disorders will be excluded in doubtful cases.

9. Pregnant / lactating women.

10. Patients who had participated in any other clinical trial since last six months.

11. Those patients contraindicated for Basti will be excluded from study.

Study & Design

• Study Type: Interventional
• Study Design: Not specified